Suppr超能文献

原发性减瘤术时的腹水体积与晚期上皮性卵巢癌患者的总生存率。

Ascites volume at the time of primary debulking and overall survival of patients with advanced epithelial ovarian cancer.

机构信息

Division of Gynecologic Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA

Division of Gynecologic Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

出版信息

Int J Gynecol Cancer. 2021 Dec;31(12):1579-1583. doi: 10.1136/ijgc-2021-002978. Epub 2021 Oct 26.

Abstract

OBJECTIVES

To investigate the impact of malignant ascites volume on the outcomes of patients with advanced epithelial ovarian carcinoma who undergo primary debulking surgery.

METHODS

Patients diagnosed with stage III-IV epithelial ovarian carcinoma and bulky intra-abdominal (TIIIC) disease between 2010 and 2015, who underwent primary debulking surgery followed by multi-agent chemotherapy and known status of residual disease, were drawn from the National Cancer Database. Based on available information, the presence and volume of malignant ascites was categorized as absent, low (<980 mL), and high (980 mL) volume. Median overall survival was determined from Kaplan-Meier curves and compared with the log rank test. A multivariate Cox model was constructed to control for confounders.

RESULTS

2493 patients were identified; 31.9% (n=795) had no ascites, 40.2% (n=1001) had low, and 28% (n=697) had high volume malignant ascites. Rate of complete gross resection was higher for patients with no ascites (65.9%) compared with those with low (35.6%) and high (23%) volume ascites (p<0.001). After controlling for stage, histology, grade, age, and comorbidities, compared with those with no ascites, patients with low (odds ratio (OR) 3.49, 95% confidence intervals (CI) 2.89 to 4.26) and high (OR 6.40, 95% CI 5.07 to 8.06) volume ascites were more likely to have gross residual disease. For patients who achieved complete gross resection after controlling for confounders compared with patients with no ascites, those with low (hazard ratio (HR) 1.37, 95% CI 1.09 to 1.72) and high volume ascites (HR 1.94, 95% CI 1.47 to 2.55) had worse overall survival. Similarly, patients with low volume ascites had better survival compared with those with high volume ascites (HR 0.71 95% CI 0.54 to 0.93).

CONCLUSIONS

The presence and volume of malignant ascites at the time of primary debulking surgery was associated with the likelihood of achieving a complete gross resection and worse overall survival.

摘要

目的

探讨原发性肿瘤细胞减灭术治疗晚期上皮性卵巢癌患者时,恶性腹水体积对患者结局的影响。

方法

本研究从国家癌症数据库中提取了 2010 年至 2015 年间诊断为 III-IV 期上皮性卵巢癌和腹腔内大肿块(TIIIC 期)疾病、接受原发性肿瘤细胞减灭术+多药化疗,并明确残余疾病状态的患者。根据现有资料,将恶性腹水的存在和体积分为无、低(<980ml)和高(980ml)。通过 Kaplan-Meier 曲线确定中位总生存期,并采用对数秩检验进行比较。构建多变量 Cox 模型以控制混杂因素。

结果

共纳入 2493 例患者;31.9%(n=795)无腹水,40.2%(n=1001)腹水低,28%(n=697)腹水高。无腹水患者完全肉眼肿瘤切除率(65.9%)高于低腹水(35.6%)和高腹水(23%)患者(p<0.001)。在校正分期、组织学、分级、年龄和合并症后,与无腹水患者相比,低腹水(比值比[OR]3.49,95%置信区间[CI]2.89 至 4.26)和高腹水(OR 6.40,95%CI 5.07 至 8.06)患者更有可能有肉眼残留肿瘤。在校正混杂因素后,与无腹水患者相比,完全肉眼肿瘤切除的患者中,低腹水(风险比[HR]1.37,95%CI 1.09 至 1.72)和高腹水(HR 1.94,95%CI 1.47 至 2.55)患者的总体生存更差。同样,低腹水患者的生存情况优于高腹水患者(HR 0.71,95%CI 0.54 至 0.93)。

结论

原发性肿瘤细胞减灭术时恶性腹水的存在和体积与实现完全肉眼肿瘤切除和总体生存较差相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验